Bullock James
SEC CIK 1172340 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AORT | ARTIVION, INC. | Dir | 76.2K | — | — | 5 | 2022-06-01 | 2026-05-18 |
Most active insiders at AORT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mackin James P | Pres, CEO | — | $9.72M |
| 2 | Stanton Marshall S. | SVP, Clinical, MD Affair | — | $3.43M |
| 3 | Holloway Jean F | SVP, GC | — | $2.54M |
| 4 | Davis John E | Chief Commercial Off | — | $1.75M |
| 5 | GREEN ANDREW M | SVP, Regulatory, Quality | — | $1.43M |
| 6 | Horton Amy | VP, CAO | — | $870.1K |
| 7 | Berry Lance A | EVP, COO, CFO, Treas | — | $803.2K |
| 8 | Hoff Elizabeth A | Dir | — | $189.4K |
| 9 | SEMEDO ANTHONY B. | Dir | — | — |
| 10 | Borgstrom Marna P | Dir | — | — |
| 14 | Bullock James | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 20:30 | 2026-05-18 | AORT | ARTIVION, INC. | Bullock James | Dir | A - Grant | $0.00 | +7,576 | 76.2K | +11% | $0 | |
| 2025-05-27 | 2025-05-22 | AORT | ARTIVION, INC. | Bullock James | Dir | A - Grant | $0.00 | +6,325 | 68.6K | +10% | $0 | |
| 2024-06-03 | 2024-05-30 | AORT | ARTIVION, INC. | Bullock James | Dir | A - Grant | $0.00 | +6,289 | 62.3K | +11% | $0 | |
| 2023-06-08 | 2023-06-06 | AORT | ARTIVION, INC. | Bullock James | Dir | A - Grant | $0.00 | +9,709 | 56.0K | +21% | $0 | |
| 2022-06-03 | 2022-06-01 | AORT | ARTIVION, INC. | Bullock James | Dir | A - Grant | $19.04 | +7,878 | 46.3K | +20% | +$150.0K |
Purchase Sale Sale after option exercise All abbreviations